What Pharma Executives Secretly Think About the Future (But Won’t Admit Publicly)
The Medical Futurist
MAY 12, 2025
For example, the generative AI model developed in collaboration between NVIDIA and Recursion Pharmaceuticals demonstrated its unique screening prowess. It can screen more than 2.8 One early example is Roche’s acquisition of diabetes management app MySugr. There is a growing number of DTx solutions for a range of conditions.
52 
Let's personalize your content